Improved Synthesis of Bradykinin
One of the major problems of peptide synthesis is protection of the guanido function of arginine. This has been accomplished by a variety of methods including even protonation (cf. SCHR6DER and LOB~E ~). There has been no really adequate solution to the simultaneous requirements of introduction of the protecting group in high yield, inertness to the usual reagents and conditions of peptide synthesis, and removal in high yield under mild conditions.
Probably the most attractive guanido protecting group would be p-toluene-sulfonyl were it not that sodiumliquid ammonia reduction is required for its removal. We have now found that liquid hydrogen fluoride at 0°C removes the NG-tosyt group rapidly and cleanly z. The synthesis of bradykinin provides an example.
Z-Arg(Tos)-Pro-Pro-Gly-Phe-Ser-Pro-Ph e-Arg(Tos) ~,4 was hydrogenated ~ in 90% acetic acid over palladium black at 4 atmospheres and room temperature. The crude product was purified by countercurrent distribution 7 in methanol-water-chloroform-carbon tetrachloride 37:10:26:27 for 200 transfers. Arg(Tos) l-Arg(Tos)9-bradykinin was obtained as an amorphous powder, giving a theoretical curve in the above countercurrent distribution, K = 2.33, and homogeneous on silica t.l.c, in n-butanol-acetic acid- A sample of Arg(Tos)~-Arg(Tos)~-bradykinin (0.500 g) was dissolved in 25 ml of liquid hydrogen fluoride and the solution stirred 1/~ h at 0 ° C. The solution was placed in a 20°C bath and the hydrogen fluoride pumped off under vacuum over a period of about 1/~ h 1.~. The residue was dried in a vacuum desiccator over potassium hydroxide pellets and purified by gradient elution chromatography 7 on a weakly acidic ion exchange resin (IRC-50) using a linear gradient from 0.1 N acetic acid to glacial acetic acid.
The appropriate fractions were combined and lyophilized giving bradykinin as a white powder, 0.298 g (68% yield calculated as the triacetate). Amino acid analysis: Arg 2.1; Pro 2.8; Gly 1.0; Phe 2.1; Ser 0.9. Duplicate bioassays gave potencies of 1.35 and 1.25 bradykinin. We may have the purest bradykinin yet reported. The hydrogen fluoride method is now being used in the synthesis of potential competitive inhibitors of bradykinin. 
Zusammen

D-5-Chloro-2-(et -hydroxybenzyl)benzimidazole and imidazoles as Inhibitors of Poliovirus Multiplication
As 5-chloro-2-(ct-hydroxybenzyl)benzimidazole (5-chloro-HBB) (I; R = H, R' = C1) markedly inhibits the multiplication of type 2 poliovirus x, it is important to decide if the activity is shared by both optical isomers and how it is influenced by N-alkylation.
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We have determined (a) the maximum concentrations 
